PHAR logo

PHAR
Pharming Group

968
Mkt Cap
$1.21B
Volume
8,324.00
52W High
$21.34
52W Low
$8.00
PE Ratio
476.04
PHAR Fundamentals
Price
$17.09
Prev Close
$16.98
Open
$17.57
50D MA
$16.35
Beta
0.48
Avg. Volume
23,841.21
EPS (Annual)
$0.0415
P/B
4.33
$1,255.63
Loading...
Loading...
News
all
press releases
Pharming Group (OTCMKTS:PHGUF) Shares Gap Up - Should You Buy?
Pharming Group (OTCMKTS:PHGUF) Shares Gap Up - Still a Buy...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Receives Average Recommendation of "Hold" from Brokerages
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) has been given an average recommendation of "Hold" by the five analysts that are presently covering the firm, Marketbeat.com reports...
MarketBeat·1d ago
News Placeholder
Pharming Group (NASDAQ:PHAR) Coverage Initiated at Canaccord Genuity Group
Canaccord Genuity Group began coverage on Pharming Group in a research report on Friday. They set a "buy" rating and a $37.00 price target for the company...
MarketBeat·2d ago
News Placeholder
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Up 33.9% in March
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 13th, there was short interest totaling...
MarketBeat·13d ago
News Placeholder
HC Wainwright Reaffirms "Buy" Rating for Pharming Group (NASDAQ:PHAR)
HC Wainwright reaffirmed a "buy" rating and issued a $37.00 price target on shares of Pharming Group in a research note on Tuesday...
MarketBeat·18d ago
News Placeholder
Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Should You Buy?
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Should You Buy...
MarketBeat·26d ago
News Placeholder
HC Wainwright Estimates Pharming Group Q3 Earnings
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Free Report) - Investment analysts at HC Wainwright issued their Q3 2026 earnings per share (EPS) estimates for shares of Pharming Group in a report...
MarketBeat·27d ago
News Placeholder
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Significant Growth in Short Interest
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) was the recipient of a significant growth in short interest in February. As of February 27th, there was short interest totaling...
MarketBeat·27d ago
News Placeholder
Pharming Group (NASDAQ:PHAR) Earns "Outperform" Rating from Oppenheimer
Oppenheimer reissued an "outperform" rating and set a $41.00 target price (down from $42.00) on shares of Pharming Group in a research note on Friday...
MarketBeat·29d ago
News Placeholder
HC Wainwright Predicts Pharming Group Q1 Earnings
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Free Report) - HC Wainwright issued their Q1 2026 earnings per share estimates for Pharming Group in a research report issued on Thursday, March 12th...
MarketBeat·30d ago
<
1
2
...
>

Latest PHAR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.